Your browser is no longer supported. Please, upgrade your browser.
Settings
GKOS Glaukos Corporation daily Stock Chart
GKOS [NYSE]
Glaukos Corporation
Index- P/E- EPS (ttm)-0.11 Insider Own0.30% Shs Outstand34.71M Perf Week9.04%
Market Cap1.20B Forward P/E- EPS next Y-0.11 Insider Trans-93.55% Shs Float33.33M Perf Month17.20%
Income-3.70M PEG- EPS next Q-0.09 Inst Own- Short Float15.24% Perf Quarter11.43%
Sales163.50M P/S7.35 EPS this Y-102.20% Inst Trans7.18% Short Ratio8.06 Perf Half Y26.40%
Book/sh4.12 P/B8.40 EPS next Y102.90% ROA-2.30% Target Price39.38 Perf Year-7.16%
Cash/sh3.28 P/C10.56 EPS next 5Y40.00% ROE-2.70% 52W Range23.08 - 44.76 Perf YTD34.97%
Dividend- P/FCF114.44 EPS past 5Y66.70% ROI-1.70% 52W High-22.65% Beta-
Dividend %- Quick Ratio7.20 Sales past 5Y130.90% Gross Margin86.80% 52W Low50.03% ATR1.35
Employees387 Current Ratio7.90 Sales Q/Q11.70% Oper. Margin-3.80% RSI (14)56.22 Volatility3.04% 3.81%
OptionableYes Debt/Eq0.00 EPS Q/Q-436.10% Profit Margin-2.30% Rel Volume0.49 Prev Close34.50
ShortableYes LT Debt/Eq0.00 EarningsMay 09 AMC Payout- Avg Volume630.29K Price34.62
Recom1.70 SMA203.90% SMA507.95% SMA2009.06% Volume309,662 Change0.35%
Apr-13-18Downgrade Stifel Buy → Hold $39 → $32
Mar-01-18Reiterated Cantor Fitzgerald Buy $48 → $43
Mar-02-17Reiterated Cantor Fitzgerald Overweight $45 → $54
Jan-06-17Upgrade Stifel Hold → Buy $42 → $45
Oct-27-16Initiated Wells Fargo Outperform
Aug-02-16Reiterated Cantor Fitzgerald Buy $35 → $41
Jun-03-16Initiated Cantor Fitzgerald Buy $35
Apr-08-16Initiated Stifel Hold
Feb-09-16Initiated Piper Jaffray Overweight $19
Jul-20-15Initiated JP Morgan Overweight $38
Jul-20-15Initiated Goldman Neutral $29
Jul-20-15Initiated Cantor Fitzgerald Buy $35
Jul-20-15Initiated BofA/Merrill Buy
May-16-18 08:20AM  New Research Coverage Highlights Ellie Mae, Micron Technology, Applied Optoelectronics, Acadia Realty Trust, Glaukos, and Noble Energy Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-12-18 05:47PM  Edited Transcript of GKOS earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-09-18 06:16PM  Glaukos: 1Q Earnings Snapshot Associated Press
04:15PM  Glaukos Corporation Announces First Quarter 2018 Financial Results Business Wire
May-02-18 07:00AM  Glaukos Announces Participation in Bank of America Merrill Lynch 2018 Health Care Conference Business Wire
Apr-23-18 08:19AM  Is SPDR S&P Health Care Equipment ETF (XHE) a Hot ETF Right Now? Zacks
Apr-19-18 04:30PM  Glaukos Corporation to Release First Quarter 2018 Financial Results after Market Close on May 9 Business Wire
Apr-14-18 03:30PM  IDE Pivotal Trial Results for Glaukos iStent inject® Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery Business Wire
08:00AM  Glaukos Files Patent Infringement Lawsuit Against Ivantis, Inc. Business Wire
Apr-13-18 12:45PM  Why Glaukos Corp. Is Sinking Today Motley Fool -9.94%
09:27AM  Stifel's Doctor Survey Triggers Glaukos Downgrade Benzinga
Apr-11-18 07:00AM  Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive Surgery Business Wire
Mar-26-18 09:16AM  Edited Transcript of GKOS earnings conference call or presentation 28-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-02-18 07:00AM  Glaukos Announces Participation in 30th Annual ROTH Conference Business Wire
Feb-28-18 05:57PM  Glaukos tops Street 4Q forecasts Associated Press
04:10PM  Glaukos Corporation Announces Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:00PM  Glaukos Corp to Host Earnings Call ACCESSWIRE
09:35AM  Glaukos Q4 Earnings Outlook Benzinga
Feb-27-18 04:30PM  Glaukos Technologies Featured in Numerous Presentations at 2018 American Glaucoma Society Meeting Business Wire
07:00AM  International Study Shows Long-Term Titrated IOP Control with 1, 2 or 3 Glaukos iStent® Trabecular Micro-Bypass Stents in Open-Angle Glaucoma Patients Business Wire
Feb-13-18 08:10AM  Detailed Research: Economic Perspectives on Omega Healthcare Investors, Vanda Pharmaceuticals, Acushnet, Prospect Capital, Intercontinental Exchange, and Glaukos What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-08-18 07:00AM  Glaukos iStent® Trabecular Micro-Bypass Stent Reduced IOP and Lowered Medication Burden in Patients with Severe Glaucoma, According to New Study Business Wire
Feb-07-18 07:00AM  Glaukos Corporation to Release Fourth Quarter and Full Year 2017 Financial Results after Market Close on February 28 Business Wire
Jan-10-18 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
07:00AM  Glaukos Corporations iDose Travoprost Achieves Sustained IOP Reduction and Favorable Safety Profile in 12-Month Interim Cohort Business Wire
Jan-09-18 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Jan-03-18 07:00AM  Glaukos Submits IDE Application to FDA to Study iStent infinite Trabecular Micro-Bypass System Business Wire
Dec-29-17 07:50AM  Wired News - Glaukos Submits Pre-Market Approval Application to FDA For iStent Inject(R) Trabecular Micro-Bypass ACCESSWIRE
Dec-27-17 04:30PM  Glaukos Announces Participation in J.P. Morgan Healthcare Conference Business Wire
01:48PM  Glaukos Has 84% Upside Potential In 2018, According To Cantor Benzinga
07:00AM  Glaukos Announces Submission of Pre-Market Approval Application for the iStent Inject® Trabecular Micro-Bypass Business Wire
Dec-26-17 11:34AM  ETFs with exposure to Glaukos Corp. : December 26, 2017 Capital Cube
Dec-22-17 09:20AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 22, 2017 Capital Cube
08:03AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Dec-21-17 08:03AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Dec-19-17 07:00AM  Glaukos to Begin Randomized U.S. IDE Pivotal Clinical Trial for the iStent SA System Business Wire
Dec-11-17 04:30PM  Why SCANA, Glaukos, and Juno Therapeutics Slumped Today Motley Fool
08:03AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Dec-01-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-30-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
07:00AM  Glaukos Announces Issuance of New U.S. Patent Business Wire
Nov-29-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-27-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
07:30AM  Research Report Identifies Walker & Dunlop, Vanda Pharmaceuticals, Acushnet, SS&C Technologies, ManpowerGroup, and Glaukos with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-22-17 08:07AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-17-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-16-17 11:38AM  ETFs with exposure to Glaukos Corp. : November 16, 2017 Capital Cube
08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-10-17 12:46PM  Edited Transcript of GKOS earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
08:11AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Nov-07-17 07:03PM  Glaukos beats Street 3Q forecasts Associated Press -10.94%
04:15PM  Glaukos Corporation Announces Third Quarter 2017 Financial Results Business Wire
03:37PM  Is This Why Glaukos Corp. Is Tumbling Today? Motley Fool
10:00AM  Glaukos Corp to Host Earnings Call ACCESSWIRE
Oct-31-17 12:10PM  Glaukos Corp. Value Analysis (NYSE:GKOS) : October 31, 2017 Capital Cube
11:39AM  ETFs with exposure to Glaukos Corp. : October 31, 2017 Capital Cube
07:00AM  Glaukos Announces Participation in Stifel 2017 Healthcare Conference Business Wire
Oct-30-17 08:11AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : October 30, 2017 Capital Cube
Oct-24-17 07:00AM  Glaukos Corporation to Release Third Quarter 2017 Financial Results after Market Close on November 7 Business Wire
Oct-16-17 09:53AM  ETFs with exposure to Glaukos Corp. : October 16, 2017 Capital Cube
Oct-10-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Oct-09-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Oct-06-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Oct-05-17 04:45PM  Glaukos iStent® Products to be Showcased at 2017 European Society of Cataract and Refractive Surgery Business Wire
03:13PM  Why Glaukos Corp. Stock Sank 12.8% in September Motley Fool
08:46AM  Weakness Seen in Glaukos (GKOS) Estimates: Should You Stay Away? Zacks
Oct-03-17 05:06PM  Should You Be Holding Glaukos Corporation (GKOS) Right Now? Simply Wall St.
Oct-02-17 10:51AM  ETFs with exposure to Glaukos Corp. : October 2, 2017 Capital Cube
Sep-29-17 09:00AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-15-17 09:46AM  Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : September 15, 2017 Capital Cube -7.21%
Sep-14-17 12:07PM  Here's Why Glaukos Corp. Stock Is Stumbling Today Motley Fool -18.12%
10:31AM  Is It Too Late To Buy Glaukos Corporation (GKOS)? Simply Wall St.
06:00AM  Glaukos to Outline Growth Strategy at Investor Day Business Wire
Sep-12-17 08:02AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Sep-11-17 10:07AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Sep-08-17 03:00AM  IBD Rating Upgrades: Glaukos Flashes Improved Price Strength Investor's Business Daily
Sep-07-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Sep-04-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-31-17 07:00AM  Glaukos Announces 2017 Investor Day and Webcast Business Wire
Aug-30-17 04:06PM  Edited Transcript of GKOS earnings conference call or presentation 2-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-24-17 07:00AM  Glaukos Announces Participation in Wells Fargo Healthcare Conference Business Wire
Aug-22-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-21-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-17-17 08:06AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-16-17 08:05AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-12-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-11-17 08:04AM  See what the IHS Markit Score report has to say about Glaukos Corp. Markit
Aug-10-17 08:05AM  IHS Markit Score downgrades Glaukos Corp to 17 out of 100, ranking negatively in one out of three available IHS Markit categories. Markit
Aug-04-17 03:17AM  Glaukos reports 2Q loss Associated Press
Aug-03-17 01:17PM  Here's What's Pressuring Glaukos Corp Stock Today Motley Fool -7.48%
Aug-02-17 04:10PM  Glaukos Corporation Announces Second Quarter 2017 Financial Results Business Wire
Aug-01-17 06:27PM  Glaukos Corp. Value Analysis (NYSE:GKOS) : August 1, 2017 Capital Cube
09:20AM  Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : August 1, 2017 Capital Cube
Jul-24-17 04:08PM  ETFs with exposure to Glaukos Corp. : July 24, 2017 Capital Cube
Jul-19-17 08:24AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : July 19, 2017 Capital Cube
Jul-11-17 02:34PM  ETFs with exposure to Glaukos Corp. : July 11, 2017 Capital Cube
Jul-06-17 08:20AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : July 6, 2017 Capital Cube
Jun-30-17 02:57PM  ETFs with exposure to Glaukos Corp. : June 30, 2017 Capital Cube
Jun-22-17 08:12AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : June 22, 2017 Capital Cube
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration. Its product pipeline also consists of iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure; and iStent Infinite trabecular micro-bypass system, which is used as a standalone procedure in patients with refractory glaucoma. Glaukos Corporation markets its products through direct sales force in the United States and internationally, as well as through distribution partners in Europe, the Asia Pacific, Latin America, and internationally. The company was founded in 1998 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SILVERSTEIN JONATHANDirectorMar 06Sale30.70161,3214,953,2740Mar 06 07:41 PM
ORBIMED ADVISORS LLCDirectorMar 06Sale30.70161,3214,953,2740Mar 06 07:36 PM
SILVERSTEIN JONATHANDirectorMar 05Sale32.44210,5966,831,6991,523Mar 06 07:41 PM
ORBIMED ADVISORS LLCDirectorMar 05Sale32.44210,5966,831,6991,523Mar 06 07:36 PM
SILVERSTEIN JONATHANDirectorMar 02Sale32.29464,58315,002,2193,511Mar 06 07:41 PM
ORBIMED ADVISORS LLCDirectorMar 02Sale32.29464,58315,002,2193,511Mar 06 07:36 PM
Burns Thomas WilliamChief Executive OfficerJan 26Option Exercise1.2547,00058,750277,240Jan 29 07:05 PM
Burns Thomas WilliamChief Executive OfficerDec 27Option Exercise1.2520,00025,000230,240Dec 27 06:07 PM
Gilliam Joseph ECFO, SVP Corporate DevelopmentNov 22Buy23.842,10050,064102,100Nov 27 01:03 PM
Burns Thomas WilliamChief Executive OfficerSep 07Option Exercise1.7073,788125,167284,028Sep 08 05:39 PM
Burns Thomas WilliamChief Executive OfficerSep 07Sale41.3673,7883,051,872210,240Sep 08 05:39 PM
Burns Thomas WilliamChief Executive OfficerSep 05Option Exercise1.931,2122,333211,452Sep 06 08:17 PM
Burns Thomas WilliamChief Executive OfficerSep 05Sale41.251,21249,995210,240Sep 06 08:17 PM
ORBIMED ADVISORS LLCDirectorSep 05Sale39.09425,20016,621,7307,895Sep 05 09:27 PM
SILVERSTEIN JONATHANDirectorSep 05Sale39.09425,20016,621,7307,895Sep 05 09:21 PM
ORBIMED ADVISORS LLCDirectorSep 01Sale37.72110,0784,152,14211,907Sep 05 09:27 PM
SILVERSTEIN JONATHANDirectorSep 01Sale37.72110,0784,152,14211,907Sep 05 09:21 PM
ORBIMED ADVISORS LLCDirectorAug 31Sale37.8244,9221,698,95012,945Sep 05 09:27 PM
SILVERSTEIN JONATHANDirectorAug 31Sale37.8244,9221,698,95012,945Sep 05 09:21 PM
SILVERSTEIN JONATHANDirectorAug 17Sale37.85226,9208,588,92213,369Aug 17 05:27 PM
ORBIMED ADVISORS LLCDirectorAug 17Sale37.85226,9208,588,92213,369Aug 17 05:20 PM
SILVERSTEIN JONATHANDirectorAug 16Sale38.0165,5802,492,69615,509Aug 17 05:27 PM
ORBIMED ADVISORS LLCDirectorAug 16Sale38.0165,5802,492,69615,509Aug 17 05:20 PM
SILVERSTEIN JONATHANDirectorAug 15Sale38.2932,5001,244,42516,128Aug 17 05:27 PM
ORBIMED ADVISORS LLCDirectorAug 15Sale38.2932,5001,244,42516,128Aug 17 05:20 PM